Featured news

Successful outcome in US CRISPR patent interference against SNIPR Biome

“In November 2021, US “Interference” proceedings resulted in cancellation of five US patents owned by SNIPR TECHNOLOGIES. It was concluded that the technology claimed in those patents was invented earlier by The Rockefeller University. The University have their own earlier patent filing focused on that technology, which is licenced exclusively to ELIGO.”

 

The presence or absence of a single bacterial gene can trigger or aggravate a variety of diseasesI

 

 This genetic causality is being demonstrated in a growing number of therapeutic areas 

 

 

Introducing GEM – Gene Editing of the Microbiome platform

A first-in-class proprietary platform to edit the microbiome gene repertoire with unprecedented precision in vivo

 “Eligo’s technology could be as important as the discovery of penicillin.”  

– Professor Christian Brechot,
Executive director at Institut Pasteur

We are hiring!

Join Our Team

Our Partners & Investors